1-20 of 31
Tibor Keler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1865: Simultaneous de-repression of innate and adaptive immune responses through dual targeting of ILT4 and PD(L)-1 with bispecific antibodies

Laura Vitale, Mike Murphy, Jeff Weidlick, Anna Wasiuk, Thomas O'Neill, Jenifer Widger, Laura Mills-Chen, Andrea Crocker, Colleen Patterson, James Boyer, Linda Crew, Edward J. Natoli, Jay S. Lillquist, Joel Goldstein, Lawrence J. Thomas, Henry C. Marsh, Diego Alvarado, Tibor Keler
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1865.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1865
Published: 01 July 2021
View article
Journal Articles

Abstract P5-04-03: Conversion of non-T cell-inflamed triple-negative breast cancer by in situ immunomodulation of induced intratumoral cross-presenting dendritic cells

Takaaki Oba, Tibor Keler, Henry C Marsh, Scott Abrams, Fumito Ito
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-04-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P5-04-03
Published: 15 February 2020
View article
Journal Articles

Abstract 2392: CDX-527: A novel bispecific immune-modulating antibody targeting CD27 and PD-L1

Laura A. Vitale, Lawrence J. Thomas, Thomas O'Neill, Jenifer Widger, Laura Mills-Chen, Andrea Crocker, Colleen Patterson, Anna Wasiuk, Eric Forsberg, James Boyer, Crystal Sisson, Jeffrey Weidlick, Shannon Renn-Bingham, Ioannis Papayannopoulos, Russ Hammond, Joel Goldstein, Henry C. Marsh, Tibor Keler, Li-Zhen He
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2392.
DOI: https://doi.org/10.1158/1538-7445.AM2019-2392
Published: 01 July 2019
View article
Journal Articles

Abstract LB-194: First-in-human Phase I study of the CD40 agonist mAb CDX-1140 and in combination with CDX-301 (rhFLT3L) in patients with advanced cancers: Interim results

Rachel E. Sanborn, Nashat Y. Gabrail, Nina Bhardwaj, Michael S. Gordon, Mark O'Hara, Danny Khalil, Thomas Hawthorne, Richard Gedrich, Laura Vitale, Mark Rogalski, Tianshu Li, Tracey Rawls, Tibor Keler, Michael Yellin
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-194.
DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-194
Published: 01 July 2019
View article
Journal Articles

Abstract 1555: Monoclonal antibodies targeting the TAM family of receptor tyrosine kinases

Diego Alvarado, Laura Vitale, Mike Murphy, Thomas O'Neill, Andrew Proffitt, Jay Lillquist, Gwenda Ligon, Komal Patel, Anna Wasiuk, Jeff Weidlick, Jenifer Widger, Laura Mills-Chen, Andrea Crocker, Colleen Patterson, Russell A. Hammond, Li-Zhen He, Joel Goldstein, Lawrence J. Thomas, Henry C. Marsh, Tibor Keler, Richard Gedrich
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1555.
DOI: https://doi.org/10.1158/1538-7445.AM2019-1555
Published: 01 July 2019
View article
Journal Articles

Abstract 3217: Preclinical evaluation of the recombinant dendritic cell growth factor CDX-301 (Flt3L), and AST-008, a TLR9 agonist SNA

Lawrence J. Thomas, Li-Zhen He, Lauren E. Gergel, Eric M. Forsberg, Elizabeth Q. Do, James M. Boyer, April R. Baronas, Mallary Rocheleau, Kathleen M. Borrelli, Anna Wasiuk, Jeffrey Weidlick, Henry C. Marsh, Bart R. Anderson, SubbaRao Nallagatla, Richard Kang, Ekambar R. Kandimalla, Tibor Keler
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3217.
DOI: https://doi.org/10.1158/1538-7445.AM2019-3217
Published: 01 July 2019
View article
Journal Articles

Abstract 5624: Development of novel bispecific immune modulating antibodies

Laura A. Vitale, Lawrence J. Thomas, Li-Zhen He, Thomas O'Neill, Jenifer Widger, Andrea Crocker, James Testa, Karuna Sundarapandiyan, Eric Forsberg, James Boyer, James Storey, Joel Goldstein, Henry C. Marsh, Tibor Keler
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5624.
DOI: https://doi.org/10.1158/1538-7445.AM2018-5624
Published: 01 July 2018
View article
Journal Articles

Abstract CT005: FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer

Nitin Ohri, Balazs Halmos, Haiying Cheng, Tony Abraham, Tahir Yahya, Madhur Garg, William Bodner, Rafi Kabarriti, Shalom Kalnicki, Michael J. Yellin, Tibor Keler, Chandan Guha
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT005.
DOI: https://doi.org/10.1158/1538-7445.AM2018-CT005
Published: 01 July 2018
View article
Journal Articles

Abstract 3816: Efficacy of CDX-1140, an agonist CD40 antibody, in preclinical tumor models

Lawrence J. Thomas, Li-Zhen He, James Testa, Anna Wasiuk, Jeffrey Weidlick, Crystal Sisson, Laura A. Vitale, Thomas O'Neill, Eric Forsberg, Catherine D. Pilsmaker, Lauren E. Gergel, Elizabeth Q. Do, James Boyer, April R. Baronas, Mallary Rocheleau, Michelle E. Grealish, Kathleen M. Borrelli, Henry C. Marsh, Tibor Keler
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3816.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3816
Published: 01 July 2018
View article
Journal Articles

Abstract 3664: CDX-1402, a dendritic cell targeted fusion protein designed to elicit immunity to mesothelin and HER2 expressing tumors

Li-Zhen He, Jenifer Widger, James Testa, Laura Mills-Chen, Biwei Zhao, Jeff Weidlick, Crystal Sisson, Anna Wasiuk, Laura Vitale, Joel Goldstein, Henry Marsh, Tibor Keler, Venky Ramakrishna
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3664.
DOI: https://doi.org/10.1158/1538-7445.AM2017-3664
Published: 01 July 2017
View article
Journal Articles

Abstract 1373: IHC and RT-PCR assays for detection of cancer antigen NY-ESO-1 in human tissues

Abdel Halim, Rebecca G. Bagley, Lisa Dauffenbach, Eric P. Olsen, Tibor Keler
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1373.
DOI: https://doi.org/10.1158/1538-7445.AM2016-1373
Published: 15 July 2016
View article
Journal Articles

Abstract 4866: Development and characterization of novel CD40 antibody agonists for cancer immunotherapy

Laura A. Vitale, Thomas O’Neill, Jenifer Widger, Andrea Crocker, Li-Zhen He, Jeffrey Weidlick, Karuna Sundarapandiyan, James Storey, Lawrence Thomas, Joel Goldstein, Henry C. Marsh, Tibor Keler
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4866.
DOI: https://doi.org/10.1158/1538-7445.AM2016-4866
Published: 15 July 2016
View article
Journal Articles

Abstract CT023: Phase I results from the combination of an immune-activating anti-CD27 antibody (varlilumab) in combination with PD-1 blockade (nivolumab): activation across multiple immune pathways without untoward immune-related adverse events

Rachel E. Sanborn, Michael J. Pishvain, Margaret K. Callahan, Naiyer Rizvi, Harriet Kluger, Michael Yellin, Tracey Rawls, Laura Vitale, Abdel Halim, Tom Davis, Tibor Keler
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT023.
DOI: https://doi.org/10.1158/1538-7445.AM2016-CT023
Published: 15 July 2016
View article
Journal Articles

Abstract LB-081: In situ vaccination of low-grade lymphoma with intratumoral Flt3L and poly-ICLC with low-dose radiotherapy

Thomas U. Marron, Nina Bhardwaj, Linda Hammerich, Seunghee Kim-Schulze, Tibor Keler, Tom Davis, Elizabeth Crowley, Andres M. Salazar, Joshua Brody
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-081.
DOI: https://doi.org/10.1158/1538-7445.AM2016-LB-081
Published: 15 July 2016
View article
Journal Articles

Abstract 5032: Glycoprotein NMB (gpNMB) overexpression is prevalent in human cancers: pancreatic cancer, non-small cell lung cancer, head and neck cancer, and osteosarcoma

Abdel Halim, Rebecca G. Bagley, Tibor Keler
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 5032.
DOI: https://doi.org/10.1158/1538-7445.AM2016-5032
Published: 15 July 2016
View article
Journal Articles

Abstract 4209: Targeting GPNMB with 89Zr-CR011 for PET imaging of triple negative breast cancer

Bernadette V. Marquez, Supum Lee, Tibor Keler, Thomas Hawthorne, Jeremy Hoog, Shunqiang Li, Cynthia Ma, Suzanne E. Lapi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4209.
DOI: https://doi.org/10.1158/1538-7445.AM2016-4209
Published: 15 July 2016
View article
Journal Articles

Abstract 253: Synergistic antitumor activity of PD-1 signaling blockade and CD27 costimulation correlates with enhanced ratio of effector to regulatory T cells at the tumor site

Lawrence J. Thomas, Li-Zhen He, Anna Wasiuk, Lauren E. Gergel, James M. Boyer, Sarah M. Round, Henry C. Marsh, Tibor Keler
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 253.
DOI: https://doi.org/10.1158/1538-7445.AM2015-253
Published: 01 August 2015
View article
Journal Articles

Abstract 2649: Development of an antibody-drug conjugate targeting TIM-1 for the treatment of ovarian and renal cell carcinoma

Lawrence J. Thomas, Laura Vitale, Thomas O'Neill, Ree Dolnick, Paul K. Wallace, Hans Minderman, Lauren E. Gergel, Eric M. Forsberg, James M. Boyer, James R. Storey, Russell A. Hammond, Jennifer Widger, Karuna Sundarapandiyan, Andrea Crocker, Henry C. Marsh, Tibor Keler
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2649.
DOI: https://doi.org/10.1158/1538-7445.AM2014-2649
Published: 01 October 2014
View article
Journal Articles

Abstract 1239: Characterization of the response of human T cells to an agonist human anti-CD27 mAb.

Karuna Sundarapandiyan, Laura Vitale, Biwei Zhao, Thomas O'Neill, Henry Marsh, Venky Ramakrishna, Tibor Keler
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1239.
DOI: https://doi.org/10.1158/1538-7445.AM2013-1239
Published: 15 April 2013
View article
Journal Articles

Abstract 3519: Appropriate crosslinking is required for co-stimulatory activity of human CD27 antibody in a transgenic mouse model

Li-Zhen He, Naseem Prostak, Andrea Crocker, Jeffery Weidlick, Jenifer Widger, Crystal Sisson, Laura Vitale, Martin J. Glennie, Tibor Keler
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3519.
DOI: https://doi.org/10.1158/1538-7445.AM2012-3519
Published: 15 April 2012
View article